Cargando…

The attitudes of 1066 patients with cancer towards participation in randomised clinical trials

BACKGROUND: Barriers to randomised clinical trial (RCT) recruitment include failure to identify eligible patients, reluctance of staff to approach them and attitudes of some health-care professionals and patients. As part of a larger UK prospective study examining the communication and involvement i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jenkins, V, Farewell, D, Batt, L, Maughan, T, Branston, L, Langridge, C, Parlour, L, Farewell, V, Fallowfield, L
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2010
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3008615/ https://www.ncbi.nlm.nih.gov/pubmed/21119659 http://dx.doi.org/10.1038/sj.bjc.6606004

Ejemplares similares

Clinicians’ attitudes towards clinical trials of cancer therapy
por: Ford, E, et al.
Publicado: (2011)

Drivers and barriers to patient participation in RCTs
por: Jenkins, V, et al.
Publicado: (2013)

Awareness of ovarian cancer risk factors, beliefs and attitudes towards screening: baseline survey of 21 715 women participating in the UK Collaborative Trial of Ovarian Cancer Screening
por: Fallowfield, L, et al.
Publicado: (2010)

Enduring impact of communication skills training: results of a 12-month follow-up
por: Fallowfield, L, et al.
Publicado: (2003)

IMPARTER, Phase 1 of an intervention to improve patients’ understanding of gene expression profiling tests in breast cancer
por: Fallowfield, L. J., et al.
Publicado: (2022)

The informational roles and psychological health of members of 10 oncology multidisciplinary teams in the UK
por: Catt, S, et al.
Publicado: (2005)

Long-term assessment of quality of life in the Intergroup Exemestane Study: 5 years post-randomisation
por: Fallowfield, L J, et al.
Publicado: (2012)

Do drugs offering only PFS maintain quality of life sufficiently from a patient’s perspective? Results from AVALPROFS (Assessing the ‘VALue’ to patients of PROgression Free Survival) study
por: Jenkins, V., et al.
Publicado: (2018)

The views of patients and the general public about expensive anti-cancer drugs in the NHS: a questionnaire-based study
por: Jenkins, Valerie A, et al.
Publicado: (2011)

Describing randomisation: patients' and the public's preferences compared with clinicians' practice
por: Jenkins, V, et al.
Publicado: (2002)

Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy
por: Jenkins, V, et al.
Publicado: (2000)

Statistical methods in randomised controlled trials for delirium
por: Farewell, Daniel, et al.
Publicado: (2012)

Adherence to hormone therapy in a chemoprevention randomised trial
por: Atkins, L, et al.
Publicado: (2008)

Improving decision making about clinical trial participation – a randomised controlled trial of a decision aid for women considering participation in the IBIS-II breast cancer prevention trial
por: Juraskova, I, et al.
Publicado: (2014)

Patients' and oncologists' views on the treatment and care of advanced ovarian cancer in the UK: results from the ADVOCATE study
por: Jenkins, V, et al.
Publicado: (2013)

Pulmonary Metastasectomy versus Continued Active Monitoring in Colorectal Cancer (PulMiCC): a multicentre randomised clinical trial
por: Treasure, Tom, et al.
Publicado: (2019)

1066 Delay in the Norwegian Immunisation Programme
por: Riise, Oystein
Publicado: (2014)

A Mixed-Methods Pilot Study of Perinatal Risk and Resilience During COVID-19
por: Farewell, Charlotte V., et al.
Publicado: (2020)

The preferences of 600 patients for different descriptions of randomisation
por: Jenkins, V, et al.
Publicado: (2005)

The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600)
por: Giorgi Rossi, P, et al.
Publicado: (2011)

Closing Symposium of the DFG Research Unit FOR 1066
por: Radespiel, Rolf, et al.
Publicado: (2016)

The four orchestral suites, BWV 1066-1069 /
por: Bach, Johann Sebastian, 1685-1750
Publicado: (2000)

A randomised controlled trial of nurse-managed trial conclusion following early phase cancer trial participation
por: Cox, K, et al.
Publicado: (2005)

4 Ouvertüren, BWV 1066-1069 Suites ; Ouvertüre BWV 1070 /
por: Bach, Johann Sebastian, 1685-1750
Publicado: (1986)

Dirichlet negative multinomial regression for overdispersed correlated count data
por: Farewell, Daniel M., et al.
Publicado: (2013)

Study design
por: Farewell, Vernon T., et al.
Publicado: (2016)

Cost-effectiveness analysis of anastrozole vs tamoxifen in adjuvant therapy for early stage breast cancer in the United Kingdom: the 5-year completed treatment analysis of the ATAC (‘Arimidex’, Tamoxifen alone or in combination) trial
por: Mansel, R, et al.
Publicado: (2007)

Using linear increment models for the imputation of missing composite outcomes in randomized trials
por: O’Keeffe, Aidan G, et al.
Publicado: (2011)

English society in the early middle ages, (1066-1307) /
por: Stenton, Doris Mary
Publicado: (1981)

1066 and all that : A memorable history of England, comprising all the parts you can remember, including 103 Good things, 5 bad Kings, and 2 Genuine Dates
por: Sellar, Walter Carruthers
Publicado: (1960)

Factors affecting attitudes toward colorectal cancer screening in the primary care population
por: Taskila, T, et al.
Publicado: (2009)

HPV vaccination among ethnic minorities in the UK: knowledge, acceptability and attitudes
por: Marlow, L A V
Publicado: (2011)

A Survey of Patient Attitudes Toward Participation in Biopsy-Based Kidney Research
por: Moledina, Dennis G., et al.
Publicado: (2017)

Commentary: Dr John Brownlee MA, MD, DSc, DPH (Cantab), FRFPS, FSS, FRMetS (1868–1927), public health officer, geneticist, epidemiologist and medical statistician
por: Farewell, Vern T, et al.
Publicado: (2013)

Patients' preferences for adjuvant endocrine therapy in early breast cancer: what makes it worthwhile?
por: Duric, V M, et al.
Publicado: (2005)

1066. Antimicrobial Stewardship Program: Audit and Feedback for Continued Improvement
por: Wang, Joseph, et al.
Publicado: (2019)

Long-term antibiotics for prevention of recurrent urinary tract infection in older adults: systematic review and meta-analysis of randomised trials
por: Ahmed, Haroon, et al.
Publicado: (2017)

Characteristics and outcomes of patients with advanced non-small-cell lung cancer who declined to participate in randomised clinical chemotherapy trials
por: Tanai, C, et al.
Publicado: (2009)

Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer
por: Hurt, C N, et al.
Publicado: (2017)

A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?
por: Maughan, T S, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ndn2svn5ovd87s6uk24to11lvt